Latham & Watkins advised IDEAYA Biosciences, while Davis Polk advised the underwriters in the offering.IDEAYA Biosciences, Inc. executed its public offering of 5,333,333 shares of common stock at…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
